| ACE | Angiotensin-converting-enzyme |
| AH | Arterial hypertension |
| AO | Atypical odontalgia |
| BMS | Burning mouth syndrome |
| CACC | Calcium-activated chloride channels |
| CGRP | Calcitonin gene-related peptide |
| CKD | Chronic kidney disease |
| CVD | Cardiovascular disease |
| EGF | Epidermal growth factor |
| FDA | Food and drug administration |
| GFR | Glomerular filtration rate |
| GECs | Gingival epithelial cells |
| GLUT2 | Glucose transporter 2 |
| HDL | High-density lipoproteins |
| HIV-DSPN | HIV-associated distal sensory polyneuropathy |
| HOMA-IR | Homeostasis model assessment of insulin resistance |
| JAK/STAT | Janus kinase/signal transducer and activator of transcription |
| LDL | Low-density lipoproteins |
| LXR | Liver X receptor |
| mAChRs | Muscarinic acetylcholine receptors |
| NF-kB | Nuclear factor-kB |
| NGF | Nerve growth factor |
| NO | Nitric oxide |
| OH-1 | Heme oxygenase-1 |
| OED | Oral epithelial dysplasia |
| PDX-1 | Pancreatic duodenal homebox-1 |
| pERK | phosphorylated kinase |
| PHN | Post-herpetic neuropathy |
| PI3/AKT | Phosphoinositide 3-kinase/protein kinase B |
| PPARα | Peroxisome proliferators-activated receptor-α |
| PTNN | Painful post-traumatic trigeminal neuropathyoma |
| SMG | Submandibular gland |
| SNT | Solitary nucleus tract |
| SP | Substance P |
| TAK1/MAPK | Transforming growth factor-β-activated kinase 1/mitogen-activated protein-kinase |
| TG | Triglycerides |
| TJs | Tight junctions |
| TM1-6 | 6 transmembrane regions |
| TMD | Temporomandibular disorder |
| TN | Trigeminal neuralgia |
| TNF-α | Tumor necrosis factor-α |
| TRCs | Taste receptor cells |
| TRPV | Transient receptor potential vanilloid |
| Vc | Caudal trigeminal subnucleus |